section 8
on 16 May 2009
Last Applicant/ Owned by
863A MITTEN ROAD
BURLINGAME
CA
94010
Serial Number
75191196 filed on 01st Nov 1996
Registration Number
2194159 registered on 06th Oct 1998
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
formulated nucleic acid pharmaceutical preparations for the treatment of autoimmune diseases, acquired diseases in the nature of coronary artery disease, lung cancer, and melanoma, and genetic diseases in the nature of cystic fibrosis, asthma, breast cancer, and ovarian cancer The mark consists, in part, of a stylized representation of an hourglass.
formulated nucleic acid pharmaceutical preparations for the treatment of autoimmune diseases, acquired diseases in the nature of coronary artery disease, lung cancer, and melanoma, and genetic diseases in the nature of cystic fibrosis, asthma, breast cancer, and ovarian cancer
30th Sep 1996
30th Sep 1996
No 75191196
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
19.13.25 -
Other receptacles for laboratory use, including beakers
26.01.01 -
Circles as carriers or as single line borders
26.19.01 -
Spheres
The mark consists, in part, of a stylized representation of an hourglass.
| Status Date | Action Taken |
|---|---|
| 16th May 2009 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| 07th Aug 2007 | CASE FILE IN TICRS |
| 27th Oct 2004 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 06th Oct 2004 | REGISTERED - SEC. 8 (6-YR) FILED |
| 06th Oct 2004 | TEAS SECTION 8 RECEIVED |
| 02th Jan 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 06th Oct 1998 | REGISTERED-PRINCIPAL REGISTER |
| 17th Aug 1998 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 15th Jul 1998 | ASSIGNED TO EXAMINER |
| 09th Jul 1998 | STATEMENT OF USE PROCESSING COMPLETE |
